Clinuvel Pharmaceuticals Limited is globally headquartered in Melbourne, Victoria, Australia. In addition to its corporate headquarters in Australia, the international biopharmaceutical enterprise maintains key operational footprints, subsidiary offices, and clinical management infrastructure in North America and Europe—including offices in the United States and Switzerland—to manage global clinical trials, regulatory compliance, and international commercial distribution for its specialized photoprotective and systemic medical product lines.